Develops peptide-based therapeutics for the treatment of human hormone diseases, prostate cancer endometriosis, and inflammatory diseases. Includes therapeutic targets and profile of facilities in Waltham, Massachusetts. (Nasdaq: PRCS)
Technology for MHC epitope removal, glycosylation to optimize pharmacokinetics, masking immune recognition sites and engineering monoclonal antibodies. Includes discovery programs, partnering opportunities in Monrovia, California. ImmunoPDA™ Technology Product Sheet Caltech spin-off developing proteomic technologies to accelerate drug discovery.
Developing a pulmonary insulin delivery system, and immunotherapy of cancer, by identifying tumor-related antigens, DNA and peptide-based drugs evoking cell-mediated responses. Located in Valencia, California.
Development of superactive hormones and growth factors for therapeutic applications. Based in Rockville, Maryland, USA.
Develops late-stage anti-infective and preclinical antibiotics by carbohydrate technology.
Business /
Biotechnology_and_Pharmaceuticals /
Pharmaceuticals /
Research_and_Development
|